Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2

Abstract excerpt

We have examined whether primary human muscle-derived cells can be used in ex vivo gene therapy to deliver BMP-2 and to produce bone in vivo. Two in vitro experiments and one in vivo experiment were used to determine the osteocompetence and BMP-2 secretion capacity of cells isolated from human skeletal muscle. We isolated five different populations of primary muscle cells from human skeletal muscle in three...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Tissue Engineering Materials
• Share to Mesenchymal stem cell research
• Share to Tissue Engineering and Regenerative Medicine